Terms: = Lung cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Staging
139 results:
1. Quality improvement mechanisms to improve lymph node staging for lung cancer: Trends from a statewide database.
Kalata S; Reddy RM; Norton EC; Clark MJ; He C; Leyden T; Adams KN; Popoff AM; Lall SC; Lagisetty KH
J Thorac Cardiovasc Surg; 2024 Apr; 167(4):1469-1478.e3. PubMed ID: 37625618
[TBL] [Abstract] [Full Text] [Related]
2. Long-Term Survival of American Joint Committee on cancer 8th Edition staging Descriptors for Clinical M1a Non-Small Cell lung cancer.
Kumar A; Xu B; Srinivasan D; Potter AL; Raman V; Lanuti M; Yang CJ; Auchincloss HG
Chest; 2024 Mar; 165(3):725-737. PubMed ID: 37544427
[TBL] [Abstract] [Full Text] [Related]
3. Discordance between clinical and pathologic staging and the timeliness of care of non-small cell lung cancer patients diagnosed with operable tumors.
Taylor O; Boardman G; Bentel J; Laycock A
Asia Pac J Clin Oncol; 2023 Dec; 19(6):706-714. PubMed ID: 36707405
[TBL] [Abstract] [Full Text] [Related]
4. Access to Care Limits lung cancer Screening Eligibility in an Urban Safety Net Hospital.
Dollar KR; Neutel BS; Hsia DW
J Prim Care Community Health; 2022; 13():21501319221128701. PubMed ID: 36200665
[TBL] [Abstract] [Full Text] [Related]
5. Adjuvant radiation therapy improves survival in stage IIIA (N2) non-small cell lung cancer with persistent N2 disease after neoadjuvant chemotherapy.
Komiya T; Takamori S; Wilding G
Radiother Oncol; 2022 Nov; 176():234-238. PubMed ID: 36192229
[TBL] [Abstract] [Full Text] [Related]
6. Characterization of metastatic Non-Small Cell lung cancer and Oligometastatic Incidence in an Era of Changing Treatment Paradigms.
No HJ; Raja N; Von Eyben R; Das M; Roy M; Myall N; Neal J; Wakelee H; Chin A; Diehn M; Loo BW; Chang DT; Pollom EL; Vitzthum LK
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):603-610. PubMed ID: 35654305
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence of sarcopenia in patients with solid tumors: A meta-analysis based on 81,814 patients.
Surov A; Wienke A
JPEN J Parenter Enteral Nutr; 2022 Nov; 46(8):1761-1768. PubMed ID: 35633306
[TBL] [Abstract] [Full Text] [Related]
8. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
[TBL] [Abstract] [Full Text] [Related]
9. Identification and Validation of the Prognostic Impact of metastatic Prostate cancer Phenotypes.
Labe SA; Wang X; Lehrer EJ; Kishan AU; Spratt DE; Lin C; Morgans AK; Ponsky L; Garcia JA; Garrett S; Wang M; Zaorsky NG
Clin Genitourin Cancer; 2022 Aug; 20(4):371-380. PubMed ID: 35383004
[TBL] [Abstract] [Full Text] [Related]
10. Disease Burden on PET Predicts Outcomes for Advanced NSCLC Patients Treated with First-Line Immunotherapy.
Andraos TY; Halmos B; Cheng H; Huntzinger C; Shirvani SM; Ohri N
Clin Lung Cancer; 2022 Jun; 23(4):291-299. PubMed ID: 35382980
[TBL] [Abstract] [Full Text] [Related]
11. Missed Opportunities? An Observational Analysis of lung cancer Screening Utilization Amongst Patients With lung cancer.
Olazagasti C; Ehrlich M; Kohn N; Aviles K; Hoilett A; Seetharamu N
Cancer Control; 2022; 29():10732748221077959. PubMed ID: 35157547
[TBL] [Abstract] [Full Text] [Related]
12. Routine systematic sampling versus targeted sampling during endobronchial ultrasound: A randomized feasibility trial.
Sullivan KA; Farrokhyar F; Leontiadis GI; Patel YS; Churchill IF; Hylton DA; Xie F; Seely AJE; Spicer J; Kidane B; Turner SR; Yasufuku K; Hanna WC
J Thorac Cardiovasc Surg; 2022 Jul; 164(1):254-261.e1. PubMed ID: 35031139
[TBL] [Abstract] [Full Text] [Related]
13. Persistent N2 After Induction Is Not a Contraindication to Surgery for lung cancer.
Andrews WG; Louie BE; Castiglioni M; Dhamija A; Farivar AS; Chansky J; White PT; Aye RW; Vallières E; Bograd AJ
Ann Thorac Surg; 2022 Aug; 114(2):394-400. PubMed ID: 34890568
[TBL] [Abstract] [Full Text] [Related]
14. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.
Vaarwerk B; Breunis WB; Haveman LM; de Keizer B; Jehanno N; Borgwardt L; van Rijn RR; van den Berg H; Cohen JF; van Dalen EC; Merks JH
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012325. PubMed ID: 34753195
[TBL] [Abstract] [Full Text] [Related]
15.
Mittlmeier LM; Todica A; Gildehaus FJ; Unterrainer M; Beyer L; Brendel M; Albert NL; Ledderose ST; Vettermann FJ; Schott M; Rodler S; Marcon J; Ilhan H; Cyran CC; Stief CG; Staehler M; Bartenstein P
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1711-1720. PubMed ID: 34708249
[TBL] [Abstract] [Full Text] [Related]
16. Reconsidering the American Joint Committee on cancer Eighth Edition TNM staging Manual Classifications for T2b and T3 NSCLC.
Kumar A; Kumar S; Gilja S; Potter AL; Raman V; Muniappan A; Liou DZ; Jeffrey Yang CF
J Thorac Oncol; 2021 Oct; 16(10):1672-1683. PubMed ID: 34242788
[TBL] [Abstract] [Full Text] [Related]
17. Performance monitoring of EBUS for the staging and diagnosis of lung cancer: auditing the Greater Manchester EBUS service against new national standards.
Punjabi A; Al-Najjar H; Teng B; Borrill Z; Brown L; Nagarajan T; Gallagher J; Grundy S; Sundar R; Higgins C; Shackley D; Sinnott N; Balata H; Lyons J; Martin J; Brocklesby C; Crosbie P; Booton R; Evison M
BMJ Open Respir Res; 2021 Jun; 8(1):. PubMed ID: 34172527
[TBL] [Abstract] [Full Text] [Related]
18. Institutional factors associated with adherence to quality measures for stage I and II non-small cell lung cancer.
Khorfan R; Cooke DT; Meguid RA; Backhus L; Varghese TK; Farjah F; Bilimoria KY; Odell DD;
J Thorac Cardiovasc Surg; 2021 Sep; 162(3):649-660.e8. PubMed ID: 34144822
[TBL] [Abstract] [Full Text] [Related]
19. Dealing with indeterminate pulmonary nodules in colorectal cancer patients; a systematic review.
van den Broek JJ; van Gestel T; Kol SQ; van Geel AM; Geenen RWF; Schreurs WH
Eur J Surg Oncol; 2021 Nov; 47(11):2749-2756. PubMed ID: 34119380
[TBL] [Abstract] [Full Text] [Related]
20. [18F]FDG PET/MRI in rectal cancer.
Crimì F; Valeggia S; Baffoni L; Stramare R; Lacognata C; Spolverato G; Albertoni L; Spimpolo A; Evangelista L; Zucchetta P; Cecchin D; Pucciarelli S
Ann Nucl Med; 2021 Mar; 35(3):281-290. PubMed ID: 33517562
[TBL] [Abstract] [Full Text] [Related]
[Next]
